Heron Therapeutics Inc (HRTX)

3.57 +0.35 (+10.87%) USD  |  NASDAQ  |  Aug 08, 16:00
3.565 0.00 (0.00%) After-Hours: 20:00
More
Heron Therapeutics Inc Key Stats
Export
Financials

Income Statement

Revenue (TTM) 89.78M
Net Income (TTM) -231.96M
EBIT (TTM) Upgrade
EBITDA (TTM) Upgrade
Revenue (Quarterly) 23.46M
Net Income (Quarterly) -63.89M
EBIT (Quarterly) Upgrade
EBITDA (Quarterly) Upgrade
Revenue (Quarterly YoY Growth) Upgrade
EPS Diluted (Quarterly YoY Growth) Upgrade
EBITDA (Quarterly YoY Growth) Upgrade

Common Size Statements

EPS Diluted (TTM) -2.30
EPS Basic (TTM) Upgrade
Shares Outstanding 102.48M

Balance Sheet

Total Assets (Quarterly) 273.72M
Total Liabilities (Quarterly) 249.76M
Shareholders Equity (Quarterly) 23.96M
Cash and Short Term Investments (Quarterly) 111.91M
Total Long Term Assets (Quarterly) Upgrade
Total Long Term Debt (Quarterly) 149.13M
Book Value (Quarterly) Upgrade

Earnings Quality

Return on Assets Upgrade
Return on Equity Upgrade
Return on Invested Capital Upgrade

Cash Flow

Cash from Operations (TTM) -205.36M
Cash from Investing (TTM) 48.02M
Cash from Financing (TTM) 154.51M
Change in Receivables (TTM) Upgrade
Changes in Working Capital (TTM) Upgrade
Capital Expenditures (TTM) Upgrade
Ending Cash (Quarterly) Upgrade
Free Cash Flow -208.64M

Profitability

Operating Margin (TTM) Upgrade
Gross Profit Margin Upgrade
Performance, Risk and Estimates

Stock Price Performance

1 Month Total Returns (Daily) Upgrade
3 Month Total Returns (Daily) Upgrade
6 Month Total Returns (Daily) Upgrade
Year to Date Total Returns (Daily) Upgrade
1 Year Total Returns (Daily) -69.75%
Annualized 3 Year Total Returns (Daily) Upgrade
Annualized 5 Year Total Returns (Daily) Upgrade
Annualized 10 Year Total Returns (Daily) Upgrade
Annualized 15 Year Total Returns (Daily) Upgrade
Annualized All Time Total Returns (Daily) Upgrade
52 Week High (Daily) Upgrade
52 Week Low (Daily) Upgrade
52-Week High Date Sep. 27, 2021
52-Week Low Date Jun. 13, 2022

Estimates

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade

Dividends and Shares

Dividend Yield 0.00%
Dividend Yield (Forward) Upgrade
Payout Ratio Upgrade
Cash Dividend Payout Ratio Upgrade
Last Dividend Amount --
Last Ex-Dividend Date --

Management Effectiveness

Asset Utilization (TTM) Upgrade
Days Sales Outstanding (Quarterly) Upgrade
Days Inventory Outstanding (Quarterly) Upgrade
Days Payable Outstanding (Quarterly) Upgrade
Total Receivables (Quarterly) Upgrade

Current Valuation

Market Cap 365.85M
Enterprise Value 403.07M
Price 3.57
PE Ratio --
PE Ratio (Forward) Upgrade
PE Ratio (Forward 1y) Upgrade
PS Ratio 4.021
PS Ratio (Forward) Upgrade
PS Ratio (Forward 1y) Upgrade
Price to Book Value 15.27
Price to Free Cash Flow Upgrade
PEG Ratio Upgrade
EV to EBITDA Upgrade
EV to EBITDA (Forward) Upgrade
EV to EBIT Upgrade
EBIT Margin (TTM) Upgrade

Risk Metrics

Alpha (5Y) Upgrade
Beta (5Y) Upgrade
Annualized Standard Deviation of Monthly Returns (5Y Lookback) Upgrade
Historical Sharpe Ratio (5Y) Upgrade
Historical Sortino (5Y) Upgrade
Max Drawdown (5Y) 94.52%
Monthly Value at Risk (VaR) 5% (5Y Lookback) Upgrade
Other Metrics

Advanced Metrics

Piotroski F Score (TTM) Upgrade
Sustainable Growth Rate (TTM) Upgrade
Tobin's Q (Approximate) (Quarterly) Upgrade
Momentum Score Upgrade
Market Cap Score Upgrade
Quality Ratio Score Upgrade

Liquidity And Solvency

Debt to Equity Ratio 6.225
Free Cash Flow (Quarterly) -44.98M
Current Ratio Upgrade
Quick Ratio (Quarterly) Upgrade
Altman Z-Score (TTM) Upgrade
Times Interest Earned (TTM) Upgrade

Employee Count Metrics

Total Employees (Annual) Upgrade
Revenue Per Employee (Annual) Upgrade
Net Income Per Employee (Annual) Upgrade